Found 277 matching trials
Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation PHASE2 For patients with recurrent liver cancer after liver transplantation, the m...
Show More Location
Department of Liver Transplantation, the Third Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors PHASE1 This global, multicenter, open-label study will evaluate the safety and tol...
Show More Location
HonorHealth Research Institute - Bisgrove
Learn More & Join Trial
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC PHASE2 There is an unmet need for patients with intermediate stage hepatocellular ...
Show More Location
Yale New Haven Hospital
Learn More & Join Trial
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer PHASE2 This is a single arm, Phase II study using the combination of atezolizumab ...
Show More Status
Active Not Recruiting
Location
UAB Women and Infants Center
Learn More & Join Trial
Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer PHASE2 This phase II trial studies the effect of atezolizumab and bevacizumab befo...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions N/A Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Show More Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Learn More & Join Trial
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC PHASE2 The purpose of this study is to assess the efficacy and safety of RP2 in co...
Show More Location
Beverly Hills Cancer Center
Learn More & Join Trial
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma PHASE2 This research study is studying a combination of two drugs that change the ...
Show More Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Learn More & Join Trial
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway. N/A The main purpose of the study is to learn about the effectiveness and treat...
Show More Learn More & Join Trial
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD PHASE2 This research plan involves a treatment approach for advanced hepatocellula...
Show More Location
Eastern Hepatobiliary Surgery Hospital
Learn More & Join Trial